Kunming, China

Jianhua Shang

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Chinese Academy of Sciences, Kpc Pharmaceuticals, Inc., Kunming Beiao Technology Company Limited. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jianhua Shang. Retrieved from https://idiyas.com/inventor/jianhua-shang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 5.8

ph-index = 1


Location History:

  • Kunming, CN (2020)
  • Yunnan, CN (2023)

Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Jianhua Shang in Respiratory Disease Treatment

Introduction

Jianhua Shang is a notable inventor based in Kunming, China, recognized for his contributions to the biopharmaceutical field. He holds two patents that focus on innovative treatments for respiratory diseases. His work emphasizes the importance of developing effective therapeutic solutions for conditions affecting the respiratory system.

Latest Patents

One of Jianhua Shang's latest patents is titled "Use of Trezastilbenoside in Manufacture of Product for Treating and/or Preventing Disease of Respiratory System." This patent discloses the use of Trezastilbenoside in creating products aimed at treating respiratory diseases, particularly those with symptoms such as cough, expectoration, and asthma. The results indicate that Trezastilbenoside has significant efficacy in relieving cough, eliminating phlegm, alleviating asthma, and providing anti-inflammatory effects, showcasing its potential for clinical application.

Another important patent by Shang is the "Pharmaceutical Composition for Treating Respiratory Disease." This invention presents a pharmaceutical composition that includes components like picrinine, vallesamine, scholaricine, and 19-epischolaricine. The composition is designed to offer protective effects on the respiratory system and can be utilized in treating relevant diseases.

Career Highlights

Jianhua Shang has worked with prominent organizations such as KPC Pharmaceuticals, Inc. and the Chinese Academy of Sciences. His experience in these institutions has contributed to his expertise in developing innovative solutions for respiratory health.

Collaborations

Shang has collaborated with notable colleagues, including Yidan Liu and Xujuan Yang, enhancing the research and development of his inventions.

Conclusion

Jianhua Shang's innovative work in the field of respiratory disease treatment highlights his commitment to improving health outcomes through biopharmaceutical advancements. His patents reflect significant contributions to the medical community, particularly in addressing respiratory conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…